An integrated model for disease state management (DSM) in diabetes: collaboration of the community pharmacist and GP in continuity of care
|Institution:||University of Sydney|
|Chief Investigator:||Associate Professor Ines Krass|
The aim of the study was to evaluate the impact of a continuity of care model for disease state management in patients with type 2 diabetes. The model comprised an initial consultation with a specialist pharmacist in the diabetes clinic, written communication with the patient’s community pharmacist and general practitioner, followed by ongoing monitoring of the patient by the community pharmacist. A comparison was made between patients who were either assigned to a diabetes clinic and received additional support and advice from their community pharmacy and GP (intervention group) or those who were assigned to a diabetes clinic only (control group). Results show positive significant results in the intervention group. These included a:
- Significant downward trend in the mean blood glucose levels in the continuity of care patients over the six months (p=0.04).
- Significant increase (to 70%) in the proportion of blood glucose readings that fell within the range 4-8 mmol/L at six months compared to baseline (57%) (p=0.05).